Gilead Sciences, Inc. 13D and 13G filings for AlloVir, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:54 pm Purchase |
2023-12-31 | 13G | AlloVir, Inc. ALVR |
GILEAD SCIENCES INC GILD |
723,273 14.600% |
127,429 (+21.39%) |
Filing |
| 2022-08-05 5:52 pm Purchase |
2022-07-28 | 13G | AlloVir, Inc. ALVR |
GILEAD SCIENCES INC GILD |
595,844 14.800% |
595,844 (New Position) |
Filing |